Onmiscan

Active Ingredient(s): Gadodiamide
FDA Approved: * September 5, 2007
Pharm Company: * GE HEALTHCARE
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Onmiscan Overview

Gadodiamide, sold under the brand name Omniscan, is a gadolinium-based MRI contrast agent (GBCA), used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels. Contents 1 Medical uses 2 Adverse effects 3 Society and culture 4 References 5 External links Medical uses .mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatn...

Read more Onmiscan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gadodiamide

Recent Onmiscan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gadodiamide
  • Injection: 14.35gm/50ml (287mg/ml), 14.35gm/50ml(287mg/ml), 28.7gm/100ml (287mg/ml), 28.7gm/100ml(287mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Gadodiamide or a similar ingredient: (1 result)